AVAVA™ Strengthens Leadership with New Board Members
AVAVA™, a frontrunner in the realm of energy-based technology, has recently made significant strides by welcoming Clint Carnell as the Executive Chairman of the Board and Mary Fisher to its Board of Directors. These accomplished industry professionals bring decades of valuable experience that align with AVAVA's goal of expanding its footprint within the medical aesthetics industry.
Strategic Appointments to Propel Growth
The addition of Clint Carnell and Mary Fisher signals a bold move by AVAVA™ to accelerate its growth and enhance its market position. Irina Erenburg, PhD, Co-Founder and CEO of AVAVA, expressed enthusiasm regarding these appointments, highlighting their extensive backgrounds in fostering company growth and increasing shareholder value.
Clint Carnell's Proven Leadership
Clint Carnell has established himself as a visionary in the medical aesthetics industry. His experience as the former CEO of The HydraFacial Company showcases his capability in driving global expansion and securing investor interests through successful public offerings. Currently, he leads InBrace, a pioneer in dental aesthetics, and heads Greyspace Holdings, providing strategic guidance in the industry.
Mary Fisher's Extensive Experience
Joining the Board alongside Carnell is Mary Fisher, a seasoned professional with over 30 years in pharmaceuticals and biotechnology. Fisher's previous tenure as CEO of SkinMedica Inc. and her current roles at Colorescience and Dermata Therapeutics demonstrate her proficiency in brand development and strategic management. Her insights are expected to bolster AVAVA's efforts as it scales its operations.
Focal Point Technology™: A Game Changer
Both members recognize the transformative potential of AVAVA's Focal Point Technology™ in the energy-based medical device market. Clint Carnell's excitement about this technology reflects the company's innovative approach to aesthetics and its commitment to pushing boundaries further than ever before.
A Visionary Team Driving Innovation
With the addition of Clint Carnell and Mary Fisher, AVAVA™ continues to surround itself with an elite team dedicated to pioneering new advancements in medical treatments. The company's board comprises industry leaders such as Dan Browne and Dr. R. Rox Anderson, among others, further indicating its strategic focus on growth and innovation.
AVAVA™ prides itself on its pioneering efforts in medical aesthetics technology, central to which is its Focal Point Technology™. This innovative technology is designed for precision energy delivery, targeting various skin concerns effectively. By integrating experiences and insights of its board members, AVAVA is poised to revolutionize the industry.
About AVAVA™
AVAVA™ is recognized for its commitment to innovation in energy-based technologies. The company's unique approach redefines energy application, ensuring inclusivity for all skin types. With a focus on merging scientific advancement with customer care, AVAVA aims to lead the future of aesthetic technologies.
Frequently Asked Questions
What is AVAVA™ known for?
AVAVA™ is a leader in energy-based technology, particularly in the medical aesthetics sector, with innovative products designed to benefit various skin types.
Who are the new members of the AVAVA™ Board?
The new members are Clint Carnell, who serves as Executive Chairman, and Mary Fisher, who brings extensive experience in pharmaceuticals and biotechnology.
What experience does Clint Carnell bring to AVAVA™?
Clint Carnell has over 20 years in the medical aesthetics industry, including leadership positions at The HydraFacial Company and InBrace.
How does Mary Fisher contribute to AVAVA™?
Mary Fisher's expertise in brand building and strategic innovation positions her well to support AVAVA's growth and market expansion initiatives.
What is Focal Point Technology™?
Focal Point Technology™ is AVAVA's innovative method for energy delivery in medical aesthetics, aiming for unmatched precision in treatments.